Novel protein, readthrough between HOXC10 and HOXC5 (None (no well-established abbreviation; may be listed as ENSG00000273049 or "HOXC10-HOXC5 readthrough"))

The "novel protein, readthrough between HOXC10 and HOXC5" (ENSG00000273049) is annotated in databases as a putative protein-coding gene corresponding to a presumed readthrough transcript between the *HOXC10* and *HOXC5* genes, part of the HOXC gene cluster on chromosome 12. However, there is no evidence that this locus encodes a functional protein or plays any defined biological role. Unlike *HOXC10*—a well-characterized transcription factor implicated in morphogenesis and various cancers—this readthrough gene shows no established molecular, functional, or disease relevance, nor is it a known or potential pharmacological target. If your interest is in the *HOXC10* or *HOXC5* genes themselves, both have well-characterized roles, especially as transcription factors involved in development and oncology. This readthrough transcript appears to be a predicted or non-canonical entity largely uncharacterized in the literature. Summary and quality note: - This target is not recognized as a validated or functional human protein, nor as a therapeutic target or biomarker. The provided name refers to a computationally defined, likely non-functional readthrough between two bona fide genes. - Entries referencing ENSG00000273049 should be treated cautiously for pharmacological or biomedical applications, as they do not correspond to a standard gene or protein product and cannot be mapped to established molecular or therapeutic classes.

Other names

Novel protein, readthrough between HOXC10 and HOXC5ENSG00000273049V9GYH0 (UniProt/TrEMBL)GC12P054487 (previous GeneCards identifier)

None (no drugs or molecular modulators with a described mechanism of action for this entity)